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Abstract
We address the identification of optimal biomarkers for the rapid diagnosis of neonatal sepsis. We employ both canonical
correlation analysis (CCA) and sparse support vector machine (SSVM) classifiers to select the best subset of biomarkers from
a large hematological data set collected from infants with suspected sepsis from Yale-New Haven Hospital’s Neonatal
Intensive Care Unit (NICU). CCA is used to select sets of biomarkers of increasing size that are most highly correlated with
infection. The effectiveness of these biomarkers is then validated by constructing a sparse support vector machine
diagnostic classifier. We find that the following set of five biomarkers capture the essential diagnostic information (in order
of importance): Bands, Platelets, neutrophil CD64, White Blood Cells, and Segs. Further, the diagnostic performance of the
optimal set of biomarkers is significantly higher than that of isolated individual biomarkers. These results suggest an
enhanced sepsis scoring system for neonatal sepsis that includes these five biomarkers. We demonstrate the robustness of
our analysis by comparing CCA with the Forward Selection method and SSVM with LASSO Logistic Regression.
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Introduction
The identification and treatment of sepsis continues to be a
major health issue. The incidence of sepsis is particularly high in
the neonatal population, where low birth weight and other
compromising factors make it a primary cause of morbidity and
death [1–3]. Early identification and treatment are critically
important to healthy patient outcomes given the inconsistent
presentation of sepsis in terms of body temperature, which may be
either above or below normal [4–6].
The most reliable diagnostic of neonatal sepsis, often referred to
as the gold standard, is a blood culture test for bacteria. While this
test is the most reliable available, it can take 48 hours to obtain the
results. As a result, treatment must often begin before the results
are known. An additional complication is the fact that the blood
culture test can be negative for one in five subjects with sepsis
[2,7]. Thus, it is of critical importance to identify new biomarkers
that will enable fast and reliable hematological scoring systems for
sepsis in its earliest stages.
The current hematological scoring system was first proposed by
Rodwell, et al. in 1988 and is based on the following seven
quantities: total leukocyte (or White Blood Cell, WBC) count,
mature neutrophil count (also named Segs, Absolute Neutrophil
Count, or ANC), immature neutrophil count (also named Bands,
Absolute Band Count, or ABC), Immature to Total neutrophil
count ratio (IT-ratio), Platelet count (Plt), and adverse changes in
the total neutrophil count [8]. Another scoring system was
proposed in Ref. [6] that characterizes a patient as septic if any
two of the following four criteria are satisfied:




These hematological scores are supplemented by other obser-
vational evidence and measurements collected by physicians
including body temperature, blood pressure, and clinical presen-
tation in determining the course of treatment before the blood
culture results are available.
Additional diagnostic hematological biomarkers have been
studied such as C-reactive protein (CRP) [9,10] and procalcitonin
[11,12]. While these biomarkers have shown to be correlated with
sepsis, they are considered to have limited diagnostic information
[4,13]. More recently, the blood biomarker neutrophil CD64 has
proved to be particularly promising for early detection of sepsis
[14–16]. Neutrophil surface CD64 expression is a high affinity Fc
receptor for immunoglobulin G (IgG) expressed on neutrophils
(and other white blood cells). Quantities of CD64 increase
markedly when neutrophils are activated by the human body’s
response to infection, and in particular, to sepsis.
The challenge of biomarker identification is reflected by the fact
that over 3000 sepsis biomarker studies have been published with
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almost 200 candidate biomarkers evaluated [4]. Nonetheless,
clinicians are unsatisfied with the diagnostic tools currently
available for making accurate and timely sepsis diagnoses that
would also support appropriate therapies. The challenge is not to
identify single biomarkers that pass a univariate test for diagnostic
efficacy, but to determine which sets of biomarkers, when
considered as a group, yield the most accurate prognosticator.
In this investigation, we integrate two tools for discovering
information in large data sets. Embedded feature selection using a
sparse support vector machine classifier [17,18] and canonical
correlation analysis [19], a tool for identifying relationships
between two sets of variables. This two-pronged analysis provides
a powerful general tool for the identification of biomarkers useful
for multivariate scoring systems.
In this manuscript, we present a systematic study of the
multivariate diagnostic capacity of a set of ten hematological
biomarkers. Our goal is to establish a general approach that can be
used effectively on potentially much larger sets of biomarkers. We
develop an approach to identify a minimum set of predictive
biomarkers with the ultimate goal of improving the early detection
of sepsis. We verify the results by conducting an exhaustive
evaluation of all possible combinations of biomarkers. We envision
that the algorithms proposed here will be helpful tools as advances
in biomedicine produce additional candidate biomarkers arising
from new proteomic and metabolomic tests [20,21].
Results
A total of 1383 sepsis evaluations were performed on 749
neonates during the study period. Blood cultures, complete blood
counts (CBC), and neutrophil CD64 data were obtained for
n~674 of the sepsis evaluations. One evaluation was excluded due
to the high neutrophil CD64 value that skewed the results.
Evaluations were partitioned into three groups: (1) blood culture
positive septic group (n1~37), (2) clinically probable septic group
(n2~290), and (3) nonseptic group (n3~347). In this study, we
combined groups 1 and 2 and labeled these subjects as having
sepsis. Our analysis is based on the comparison between this
combined septic group (ns~327) and nonseptic group (nn~347).
See Materials and Methods for details.
Data for ten hematological biomarkers were analyzed in this
study including: (1) Age, (2) WBC count, (3) Hemoglobin count
(Hgb), (4) Hematocrit percentage (Hct), (5) Plt, (6) Segs, (7) Bands,
(8) Lymphocyte (Lymph) count as a percentage of WBC, (9)
Monocyte (Mono) count as a percentage of WBC, and (10)
neutrophil CD64 expression. Following Ref. [5], P-values were
computed for the biomarker data and all ten biomarkers were
determined to have predictive capacity.
Optimal Subsets of Biomarkers
Multivariate correlation analysis is a general tool for exploring
how variables are inter-related. Canonical correlation analysis
provides a powerful tool for discovering relationships between two
sets of variables. Given two sets of variables, CCA can identify
subsets of each set, which when combined as latent variables,
produce the maximum correlation between the two sets. In this
study, we choose one set of variables to be the sepsis score, and the
second set is taken from all possible subsets of the ten biomarkers.
CCA can thus generate an ordered list of biomarkers that are most
correlated with the sepsis score. See Materials and Methods for
details.
Here we discuss the results of applying CCA to select the best
combinations of sepsis biomarkers. We first consider the single
biomarker with highest correlation to the sepsis score. As shown in
Table 1, this biomarker is Bands. If we consider all pairs of
biomarkers, Bands and Plt possess the highest correlation with
sepsis score. We note that CD64 has the second highest correlation
with sepsis score, in the univariate sense, but improves the
correlation of Bands to sepsis score less than Plt, which has a lower
univariate correlation with sepsis score. This is due to the fact that
Bands and CD64 are more correlated than Bands and Plt, and so
less information is provided by adding CD64. Hgb enters at k~3
even though it has a very weak pairwise correlation with the sepsis
score given it also has very weak pairwise correlation with Bands
and Plt. The correlation saturates at k~5 with the following
combination set of biomarkers: Bands, CD64, Segs, WBC, and Plt.
The rest of the biomarkers do not provide significant additional
information about the sepsis score. The above analysis suggests
that these five variables should be included in our sepsis scoring
system.
Comparison with Forward Selection Method. Forward
Selection (FS) is a well known data-driven selection method, where
additional variables are added in one-by-one to improve the model
[22]. The FS method selects the single variable out of the
remaining set that gives the highest absolute correlation with the
residual vector [23]. The results from FS on the sepsis data set are
compared with those from CCA in Table 1. Both methods involve
linear correlations, but FS is a greedy algorithm, which only
produces a locally optimal solution. However, we find that up to
k~4, CCA and FS select the same subset of biomarkers. At k~5,
CCA and FS differ. Since FS can only select one feature at a time,
at k~5, FS selects Segs, while CCA selects Segs and WBC and
replaces Hgb. The manner in which we implemented CCA
ensures a globally optimal solution for each k.
In the next section, we validate this result using a classifier to
predict the sepsis score in terms of these biomarkers.
Table 1. Comparison of the Canonical Correlation Analysis
and Forward Selection of the biomarkers.
k-combination Correlation Enter Leave
Forward
Selection
1 0.563 Bands Bands
2 0.615 Plt Plt
3 0.633 Hgb Hgb
4 0.643 CD64 CD64
5 0.653 Segs, WBC Hgb Segs
6 0.660 Hgb WBC
7 0.663 Age Age
8 0.664 Lymph Hct
9 0.666 Mono Lymph
10 0.668 Hct Mono
By applying CCA for all possible k-combinations (k~1, . . . ,10), the subset of k
biomarkers with the highest correlation with the sepsis score is determined. The
‘Enter’ column indicates which biomarker is added to achieve the highest
correlation at each k. The ‘Leave’ column indicates which biomarker is
eliminated from the combination at that particular k. A biomarker will stay in
the combination until it occurs in ‘Leave’ column. For instance, for the 5-
combination, the most correlated biomarkers include Bands, Plt, CD64, Segs,
and WBC. Hgb, which was present in the 4-combination, is replaced by Segs
and WBC at level 5. The ‘Forward Selection’ column is the biomarker selected by
the forward selection method when applied one biomarker at a time.
doi:10.1371/journal.pone.0082700.t001
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The Diagnostic Classifier
We seek to construct a decision function from the biomarker
data that serves as a hematological scoring system, i.e. a function
that maps a sample vector of biomarkers to a positive or negative
sepsis diagnosis. Using the biomarkers identified by CCA above,
WBC, Plt, Segs, Bands, and CD64, we propose the linear decision
function:
d(x)~w1 WBCzw2 Pltzw3 Segszw4 Bandszw5 CD64zb:
From the sparse support vector machine approach described in





See Table 2 for the weights, wi, and their errors, and means and
standard deviations of the biomarkers. With this decision function,
if the Score is greater than or equal to zero the diagnosis is positive
for sepsis, whereas if the Score is less than zero, the diagnosis is
healthy or aseptic disease. We note that since the range of values of
the biomarkers varies widely, all values of the biomarkers are
normalized by subtracting the mean over all cases and then
dividing by the standard deviation.
The results of applying the classifier in Equation (1) to the full
sepsis dataset are shown in Table 3. We calculated the true positive
rate (TPR), true negative rate (TNR), positive predictive value
(PPV), negative predictive value (NPV), and accuracy (ACC)
(defined in Materials and Methods) for these five biomarkers. We
emphasize that there are two remaining questions of interest. How
good is the classifier? Did we identify the most predictive
biomarkers from the original set of ten? We focus on the validation
of these biomarkers in the next section.
Biomarker Validation
In this section, we have two goals. First, we will verify that the
number of biomarkers suggested by CCA, k~5, is optimal.
Secondly, we seek to provide evidence that the CCA-selected
biomarkers are optimal. To do this, we will perform an exhaustive
analysis of all possible scoring systems for the ten biomarkers.
Clearly this approach is not feasible for large sets of biomarkers,
but we exploit the fact that we only have ten to illustrate the power
of CCA biomarker selection by constructing all possible SSVM
classifiers. We used the accuracy of the resulting decision functions
for our validation.
Validation of the k~5 Classifier. For each k, we select the
k-combination set of biomarkers as identified by CCA and shown
in Table 1. We construct a decision function for each k from 1 to
10 and evaluate several measures of the quality of the scoring
system in Fig. 1. We find that each measure begins to saturate near
k~5, although one could argue that some slight improvement
could be obtained by adding one or two more biomarkers for the
given model. (We note that this particular model was not
optimized over variations in the parameter b.)
Receiver operating characteristic (ROC) curves for true positive
versus false positive rate provide additional insight into the
determination of the minimal number of biomarkers that provide
predictive information about sepsis infection. In Figure 2, we show
that the ROC curves become independent of k for k§5, and thus
k~5 is indeed the appropriate number of biomarkers. In the inset
to Figure 2, we show the ROC curve for k~5 averaged over 100
SSVM models.
Validation of the CCA Selected Biomarkers. We provide
further evidence that our CCA biomarker selection was in fact the
optimal one by applying SSVM to all possible combinations of
biomarkers for each k. We show the TPR, TNR, PPV, NPV, and
ACC for the top 20 of all possible combinations in Figure 3. It is
clear that the CCA-selected biomarkers possess the best statistical
measures for each k.
Comparison with Logistic Regression. Logistic Regres-
sion (LR) is widely used for classification problems. A LR model
can predict the outcome variable, such as the disease state ( i.e. sick
or healthy) [24], by the new predictor inputs. The LASSO (Least
Absolute Shrinkage and Selection Operator) algorithm [25] is a 1-
norm regularized logistic regression, which is extensively used for
feature selection. By the 1-norm penalty, LASSO Logistic
Regression (LLR) can achieve a sparse solution and exhibit a
significantly high tolerance to the presence of many irrelevant
features [26].
Here we also construct a LLR based classifier for each k from 1
to 10 and plot the same statistical measures of the performance of
the diagnostic system in Figure 1 as for SSVM. The sets of
Table 2. Parameters for the classifier at k = 5.
m Biomarker Mean x Standard Deviation s Weight w Standard Error of Weight e
1 WBC 14.04 8.70 0.373 0.009
2 Plt 231.37 103.38 20.876 0.012
3 Segs 39.64 17.25 20.699 0.008
4 Bands 7.92 9.61 2.691 0.018
5 CD64 2.96 2.42 0.446 0.012
The parameters of the classifier for the sepsis score given in Equation (1), including the standard errors e(m) for each biomarker weight w(m).
doi:10.1371/journal.pone.0082700.t002
Table 3. Performance of the classifier at k = 5 for SSVM and
LLR.
Method TPR TNR PPV NPV ACC
SSVM 0.838 0.905 0.893 0.856 0.875
LLR 0.740 0.960 0.945 0.797 0.853
Prediction measures for the classifier at k = 5 built by SSVM and LLR: true
positive rate (TPR), true negative rate (TNR), positive predictive value (PPV),
negative predictive value (NPV), and accuracy (ACC).
doi:10.1371/journal.pone.0082700.t003
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biomarkers determined by CCA are used for each k-combination.
We observe a similar saturation for all of the measures near k~5.
On our test data set we observe that LLR has a superior true
negative rate while its true positive rate is inferior. The variability
of the measures is substantially wider for LLR than SSVM (see
Table 3 for the LLR and SSVM performance of the classifier at
k = 5). In practice physicians may be concerned with a specific
measure, e.g., negative predictive value. In this case, either of these
methods could be used to optimize the negative predictive value.
Please see Supporting Information Text S1 for more details.
Materials and Methods
The data sets were obtained from a prospective study conducted
in the Neonatal Intensive Care Unit at Yale-New Haven Hospital
[27].This study was approved by the Yale University School of
Medicine Human Investigation Committee. Consecutive patients,
who underwent a sepsis work-up as deemed necessary by the
attending neonatologist during the time period 1/2008-6/2009,
were enrolled in the study [27].
Sepsis Evaluations
The clinical and historical features used to identify patients at
risk for sepsis include one or more of the following, as determined
by the attending neonatologist [6,28,29]: (1) respiratory compro-
mise (e.g. tachypnea, increase in frequency or severity of apnea, or
increased ventilator support); (2) cardiovascular compromise (e.g.
increased frequency or severity of bradycardic episodes, pallor,
decreased perfusion, or hypotension); (3) metabolic changes (e.g.
temperature instability, feeding intolerance, glucose instability, or
metabolic acidosis); (4) neurological changes (e.g. lethargy, hypo-
tonia, or irritability); and (5) antenatal risk factors (e.g. maternal
Group B Streptococcus (GBS) colonization without adequate
intrapartum prophylaxis, unknown maternal GBS status, maternal
temperature, chorioamnionitis, preterm labor, or prolonged
rupture of membranes). After the sepsis evaluation was performed,
we utilized the following values derived from CBC to assign a
sepsis score [8,14]: (1) Absolute Neutrophil Count (ANC) v7500
or w14500=mm3; (2) Absolute Band Count (ABC) w1500=mm3;
(3) Immature to Total neutrophil ratio (IT-ratio) w0:16; and (4)
Platelet (Plt) count v150,000=mm3. Infants who met 2 or more of
these laboratory criteria were categorized as having a positive
sepsis score. Hemoglobin was measured in the clinical hematology
laboratory using a calorimetric method. The hematocrit was
calculated after measuring the total red blood cell count (RBC)
and the mean corpuscular volume (MCV) of the RBCs. All blood
cultures were collected using standard sterile techniques. As per
unit protocol, we attempt to obtain 2 blood cultures with a
minimum of 0:5 ml. The BACTEC (Becton Dickinson and Co.,
Sparks, MD) microbial detection system was used to detect positive
blood cultures.
Neutrophil CD64 expression was measured using 50 ml of whole
blood incubated for 10 minutes at room temperature with a
saturating amount of fluorescein isothiocyanate (FITC)-conjugated
anti-CD64 monoclonal antibody or isotype control (Leuko64 kit,
Trillium Diagnostics, Scarborough, ME), followed by ammonium
chloride-based red cell lysis. Samples were washed once and re-
suspended in 0:5 ml of phosphate-buffered saline with 0.1%
bovine serum albumin. Flow cytometric analysis was accomplished
using a Becton-Dickinson FACScan (Mountainview, CA) to collect
log FITC fluorescence, log right-angle side scatter and forward
scatter on a minimum of 50,000 leukocytes. Interassay standard-
ization and neutrophil CD64 quantification were performed using
FITC calibration beads (Leuko64 kit). Data analysis was
performed using light scatter gating to define the neutrophil
population, and the neutrophil CD64 Index was quantified as
mean equivalent soluble fluorescence units using QuickCal for
Winlist (Verity Software House, Topsham, ME) with a correction
for nonspecific antibody binding by subtracting values for the
isotype control [14]. This was expressed as an absolute value.
Investigators checking and confirming the neutrophil CD64 results
were blinded to the clinical data, including the blood culture
results. Clinicians did not have access to the neutrophil CD64
values and these were not used to decide initiation or duration of
antibiotic therapy.
Evaluation Studied
Evaluations were obtained by accessing the electronic medical
record from January 2008 through June 2009. Each evaluation
typically included a CBC, two peripheral blood cultures, and other
optional cultures. A patient could undergo multiple sepsis
evaluations during admission. Since a single evaluation represent-
Figure 1. Prediction measures obtained from the (A) Sparse
Support Vector Machine and (B) LASSO Logistic Regression
methods. True positive rate (TPR), true negative rate (TNR), positive
predictive value (PPV), negative predictive value (NPV), and accuracy
(ACC) are shown for each k-combination of biomarkers selected.
doi:10.1371/journal.pone.0082700.g001
Figure 2. Receiver operating characteristic (ROC) curves. ROC
curves of TPR versus FPR for optimal sets of k biomarkers where
k~1, . . . ,10 averaged over 100 SSVM models. The shaded region in the
inset shows the standard deviation for k~5.
doi:10.1371/journal.pone.0082700.g002
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ed a separate episode of suspected sepsis and could be treated
independently, we therefore treated all evaluations equivalently in
this manuscript. Evaluations were excluded if the CBC, neutrophil
CD64, or blood culture tests were not provided in the patient
record. A total of 674 sepsis evaluations with complete hemato-
logic, neutrophil CD64, and blood culture data were used for
the analyses. (One evaluation, which was positive for
Candidanalbicans was excluded due to the high neutrophil
CD64 value that skewed the results.) Information about each
sepsis evaluation included (1) sepsis diagnosis type, (2) day of life
that the evaluation was performed, and (3) CBC data and
neutrophil CD64 expression. Ten biomarkers were included in the
analysis: Age, WBC, Hgb, Hct, Plt, Segs, Bands, Lymph, Mono,
and CD64. Additional details about the laboratory and clinical
data were recently published [27,30].
Defining Sepsis Outcome
Individual sepsis evaluations with positive blood cultures were
diagnosed as culture-proven sepsis according to the current
National Healthcare Safety Network definitions for laboratory-
confirmed bloodstream infections [31]. Individual sepsis evalua-
tions with positive sepsis scores were categorized as clinical sepsis
[8,14]. This might include infants with other infectious diagnoses
that were not accompanied by a positive blood culture, such as
pneumonia, urinary tract infection, and necrotizing enterocolitis.
Three groups of evaluations were defined, and each evaluation
was assigned to only one of the three groups. Group 1 consisted of
37 evaluations with a positive blood culture. Group 2 with
‘‘suspected sepsis’’ consisted of 290 evaluations, where the patients
lacked a definitive positive blood culture, but the clinical diagnosis
was unable to rule out bacterial infection. Group 3 consisted of
347 evaluations, for which either the blood culture or clinical
diagnosis showed no evidence of infection.
Data Preprocessing
First, each evaluation i~1, . . . ,n, with data xi, is categorized as
septic (groups 1 and 2 above) and nonseptic (group 3), where xi is a
real-valued vector with p~10 components (biomarkers) and
n~674 is the total number of evaluations. For convenience, we
labeled each evaluation using the variable yi, where yi~z1 is the
label for the septic group and yi~{1 is given to each in the
nonseptic group. To standardize the range of independent
biomarkers, we normalized the real-valued data x, a n|p matrix,






where x and xnorm are n|p matrices, x and s(x) are the mean
value and standard deviation of x for each biomarker.
Canonical Correlation Analysis
CCA is a multivariate statistical tool that facilitates the study of
interrelationships among multiple variables [19,33]. A linear
combination of variables can be chosen by CCA such that the
correlation between two sets of data is maximized [34]. In our
studies, the two sets of data are the sepsis score y and each distinct
k-combination of the p~10 biomarkers in the data matrix x. In
this investigation, CCA is used to identify the set of k-biomarkers
most correlated as a group to the sepsis score. Please see
Supplementary Text S1 for more details.
To explore the redundancy among the biomarkers, we
calculated the correlations between each possible k-combination
of x and y using CCA. By varying k from 1 (single biomarker) to p
(all biomarkers), we selected the specific set of biomarkers that
possessed the highest correlation with y for each k. The sets of
biomarkers that had the largest correlation with the sepsis score
Figure 3. Exhaustive evaluation of statistical measures. The 20 highest TPR, TNR, PPV, NPV, ACC values when SSVM was applied for all possible
combinations of k biomarkers (blue circles) from k~1, . . . ,10. The solid red circles are the values for models built using the best k biomarkers
selected by CCA.
doi:10.1371/journal.pone.0082700.g003
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and their corresponding correlation coefficients are shown in
Table 1.
Sparse Support Vector Machines (SSVM)
We applied the SSVM ensemble method to build a classifier for
each of the CCA-selected k-combination of biomarkers selected by
CCA. A linear support vector machine (SVM) is a widely used
classifier, which finds the hyperplane that separates high-dimen-
sional data with maximum margin by categories. The search of
















i jwij is the 1-norm of a vector, which induces the
sparsity in the weight vector w [17]. We refer to the solution of
Equation (3) as a sparse support vector machine (SSVM) following
Ref. [18]. Note that splitting the classes in the objective function
allows for unbalanced sample sizes.
Due to the limited size and noise of our data, a bootstrap
aggregation method was applied to build an ensemble of SSVM
classifiers using the following procedure [35,36]:
1. The data set x(k) is randomly divided into a learning set L and
a test set T . T is one third of the data.
2. Based on the bootstrap aggregation method, a bootstrap
training set LB is randomly selected from the original learning
set L with replacement. That is, LB has the same number of
samples as the original training set L, but with several training
samples appearing multiple times. Each bootstrap set LB
contains 63:2% unique samples of the original training set L.
By repeating this process 50 times, an ensemble of classifiers
fi(x), with i~1, . . . ,50, is built by the SSVM. To have the
same total cost for both false positives and false negatives, the





number of nonseptic training evaluations
number of septic training evaluations
w i t h
C{~1:0 since the results are not sensitive to the overall scale
of C+.
3. The final classification is obtained by calculating the mean of
the ensemble of 50 classifiers.
4. The random division of the data into L and T is repeated 100
times, after which we calculate the mean and standard
deviation. We used the same 100 random divisions of the
training and test sets for each k.
Calculation of Statistical Measures
The statistical measures of the performance of a classifier are
measured using ACC, TPR, TNR, NPV, and PPV. For the sake of
completeness, we include their definitions:
ACC~
number of True Positivesznumber of True Negatives
total number of samples
, ð4aÞ
TPR~
number of True Positives
number of True Positivesznumber of False Negatives
, ð4bÞ
TNR~
number of True Negatives
number of True Negativesznumber of False Positives
, ð4cÞ
NPV~
number of True Negatives
number of True Negativesznumber of False Negatives
, ð4dÞ
PPV~
number of True Positives
number of True Positivesznumber of False Positives
: ð4eÞ
Here, these statistical measures are calculated for each one of
the 100 random divisions of test sets T by the classifier built on the
bootstrap aggregation method. Their mean and standard devia-
tion are calculated from the groups obtained from the 100 random
divisions.
Discussion
Clinical Issues in Sepsis Diagnosis
The problems associated with confirming sepsis with positive
blood cultures, as mentioned earlier, has led clinicians to
investigate alternate approaches for confirmation of diagnosis of
blood-cluster negative or clinical sepsis and prevention of missed
or under treatment of neonates with antibiotics. Clinical param-
eters are notorious for their non-specific nature in detecting
infection, especially in premature neonates; however, a scoring
system based on a 7-item weighted clinical score has been
suggested [37]. In real world settings, most clinicians rely on
clinical judgment, in concert with specific hematological criteria,
to identify infants with sepsis. The hematological criteria have
usually included ANC, ABC, IT-ratio, and platelet counts, as was
done in the present study [6,14,38–43]. Unfortunately, this
approach has not proven very reliable due to the inherent
subjective nature of the clinical assessment and the variability of
the hematological parameters secondary to physiological derange-
ments and non-infectious medical conditions, and has led to over-
treatment of neonates.
It has been suggested that the addition of specific molecular
markers might improve diagnostic accuracy of neonatal sepsis.
Among the acute-phase reactants, CRP is probably the most well
studied, but its value for diagnostic accuracy has had mixed results
[7,44]. Among the newer ones, procalcitonin [45–49] and
neutrophil CD64 [14,15] have shown promise. Neutrophil
CD64 values have been reported to be sustained for at least
24 hours in neonates with sepsis [50].
Several studies have investigated the usefulness of the CD64
Index in the NICU population, albeit in much smaller cohorts, but
with promising results in both the preterm and term populations,
as well as in cases of both early-onset sepsis and late-onset sepsis
[14,51–56]. Recently, studies have suggested that the diagnostic
accuracy of neutrophil CD64 is superior to the IT-ratio [57] and
CRP [58] for the early detection of neonatal sepsis. Secondly,
testing can be done on the same sample sent for a CBC evaluation
as it requires only 50 ml of blood. Thirdly, the CD64 results can be
made available within hours of the CBC, since most clinical
laboratories in the developed and some developing countries have
flow cytometry technology. Furthermore, standard cell counters
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which use flow cytometry have the potential to incorporate anti-
CD64 antibodies and software to provide an even more rapid
enumeration of CD64 indices nearly simultaneous with CBC
results. Hence, we believe that a scoring system that can
incorporate the common CBC parameters with the neutrophil
CD64, as was done with our analyses, would provide objective
criteria for recognizing neonatal sepsis and guidance for initiation
and/or early termination of antibiotic therapy. Additional
independent validation of our results is needed before incorpora-
tion of our diagnostic sepsis score can be recommended for routine
clinical use.
Identification of the Optimal Subset of Biomarkers
We have proposed a new approach for biomarker identification
based on the integrated use of CCA and SSVM on a labeled data
set. We found that for the neonatal sepsis data our approach
produced the optimal set of k hematological biomarkers for all
possible k[f1,2, . . . ,9,10g. We validated our results by conducting
an exhaustive search of all combinations of biomarkers and
ranking them based on their classification accuracy. These results
showed that our approach produced either the absolute top
combination, or a combination of biomarkers with statistically
indistinguishable performance. Although this study explored a
relatively small set of biomarkers, the CCA approach can be
applied to potentially much larger sets by exploiting the relative
weighting of the features (see Equations S1 and S2) and selecting
only the most important features. From Equation S3, CCA
requires finding the pseudo-inverse of a k|k matrix, where k is
the number of biomarkers. Even without invoking sparse methods,
one can easily investigate systems with k of order 10,0000.
Our approach identifies Bands as the most significant biomarker
in our set for detecting neonatal sepsis. The next four most
sigificant hematological biomarkers, in order of importance,
appear to be Plt, neutrophil CD64, WBC, and Segs. We note
that, as illustrated in Figure S1, the reason for the significance of
Bands may be attributed to the fact that it is highly correlated with
subjects with a negative diagnosis while much less correlated with
subjects with a positive diagnosis. This could be related to the
significant variation in Bands for sick individuals as evidenced by
Table S1.
We explore LLR in addition to SSVM to corroborate our
results. In each case we see that an exhaustive combinatorial
evaluation of the classifiers determines that the CCA selected
biomarkers were indeed optimal. See Figures S2 and S3 for a
graphical summary of these numerical experiments. Additionally
we found that the Forward Selection results were very similar to
the biomarkers identified by CCA on this data set, i.e., Bands, Plt,
Hgb, CD64 and Segs. CCA selected WBC and not Hgb for the
best 5-combination. The classifiers using these two sets of
biomarkers perform very similarly with a very slight edge to the
CCA biomarkers. However, in general, forward selection is a
greedy algorithm and it is possible that the sets of biomarkers
identified by CCA and FS could be quite different. Classification
algorithms such as SSVM or LLR can then assist in comparing
and evaluating the selected biomarkers.
We propose that the results found in this investigation, in
particular, the new sepsis scoring system, sets the stage for
independent investigators to clinically validate these results using
alternative sepsis databases. In particular, it will be interesting to
ascertain whether this scoring system is also relevant for adults. It
is also possible to envision modifying the scoring system based on
new data related to alternative scenarios, e.g., septic adults infected
by Gram negative microorganisms. Although we propose CCA in
conjunction with SSVM as an approach for biomarker identifi-
cation, the strength of the methodology lies in the exploitation of
multivariate relationships within the data and other methods that
do this also merit further exploration.
Supporting Information
Figure S1 Heatmaps of pairwise correlations magni-
tude. The pairwise correlations were calculated for any pair of all
10 biomarkers in septic group (A) and nonseptic group (B). The
biomarkers in both x-axis and y-axis for all heatmaps are sorted
ascending by the corrlation magnitude with sepsis score. The
intensity of the color indicates the correlation magnitude in the
pair associated with the corresponding labels of x-axis and y-axis.
A high magnitude implies a strong association between two
variables.
(TIF)
Figure S2 Exhaustive evaluation of statistical measures.
The 20 highest TPR, TNR, PPV, NPV, ACC values when LLR
was applied for all possible combinations of k biomarkers (blue
circles) from k~1, . . . ,10. The solid red circles are the values for
models built using the best k biomarkers selected by CCA.
(TIF)
Figure S3 Receiver operating characteristic (ROC)
curves. ROC curves of TPR versus FPR for optimal sets of k
biomarkers where k~1, . . . ,10 averaged over 100 LLR models.
The shaded region in the inset shows the standard deviation for
k~5.
(TIF)
Table S1 Characteristics of individual biomarkers by
group. Statistical analysis of individual biomarker based on the
evaluation distributions of septic group and nonseptic group.
Results are presented as mean (standard deviation). P values are
comparisons between septic group and nonseptic group. Any
significance level of P less than 0.05 was associated with the
diagnosis.
(PDF)
Text S1 Supplementary Methods.
(PDF)
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